INTERCEPT PHARMACEUTICALS

intercept-pharmaceuticals-logo

Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases
#People #Financial #Website #More

INTERCEPT PHARMACEUTICALS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2002-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.interceptpharma.com

Total Employee:
501+

Status:
Active

Contact:
+1 646 747 1000

Email Addresses:
[email protected]

Total Funding:
567.12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins



Current Advisors List

klaus-veitinger_image

Klaus Veitinger Board Member @ Intercept Pharmaceuticals
Board_member

jonathan-silverstein_image

Jonathan Silverstein Member of the Board of Directors @ Intercept Pharmaceuticals
Board_member

not_available_image

Luca Benatti Member of Independent Board Member @ Intercept Pharmaceuticals
Board_member

srinivas-akkaraju_image

Srinivas Akkaraju Board Member @ Intercept Pharmaceuticals
Board_member

not_available_image

Nicole Williams Board Member @ Intercept Pharmaceuticals
Board_member
2008-01-01

not_available_image

Paolo Fundaro Board Member @ Intercept Pharmaceuticals
Board_member
2006-01-01

chau-khuong_image

Chau Khuong Board of Directors @ Intercept Pharmaceuticals
Board_member

lorenzo-tallarigo_image

Lorenzo Tallarigo Board Member @ Intercept Pharmaceuticals
Board_member
2008-01-01

Current Employees Featured

christian-weyer_image

Christian Weyer
Christian Weyer Executive Vice President of Research & Development @ Intercept Pharmaceuticals
Executive Vice President of Research & Development
2017-11-01

not_available_image

Drew Cronin-Fine
Drew Cronin-Fine Executive Director, US Marketing @ Intercept Pharmaceuticals
Executive Director, US Marketing
2021-10-01

sandip-kapadia_image

Sandip Kapadia
Sandip Kapadia CFO @ Intercept Pharmaceuticals
CFO

mark-pruzanski_image

Mark Pruzanski
Mark Pruzanski Founder, Strategic Advisor and Board Member @ Intercept Pharmaceuticals
Founder, Strategic Advisor and Board Member
2021-01-01

lixia-wang_image

Lixia Wang
Lixia Wang Vice President @ Intercept Pharmaceuticals
Vice President
2019-02-01

david-shapiro_image

David Shapiro
David Shapiro Chief Medical Officer @ Intercept Pharmaceuticals
Chief Medical Officer

gail-cawkwell_image

Gail Cawkwell
Gail Cawkwell Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer @ Intercept Pharmaceuticals
Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer
2018-02-01

daniel-m-bradbury_image

Daniel M. Bradbury
Daniel M. Bradbury Director @ Intercept Pharmaceuticals
Director
2016-07-01

caroline-stockwell_image

Caroline Stockwell
Caroline Stockwell VP, Head of Legal International @ Intercept Pharmaceuticals
VP, Head of Legal International
2020-10-01

not_available_image

Roberto Pellicciari
Roberto Pellicciari Co-Founder & Head of Medicinal Chemistry @ Intercept Pharmaceuticals
Co-Founder & Head of Medicinal Chemistry

Founder


mark-pruzanski_image

Mark Pruzanski

not_available_image

Roberto Pellicciari

Stock Details


Company's stock symbol is NASDAQ:ICPT

Investors List

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series C - Intercept Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Series B - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Series A - Intercept Pharmaceuticals

jafco-life-science_image

Jafco Life Science

Jafco Life Science investment in Venture Round - Intercept Pharmaceuticals

genextra_image

Genextra

Genextra investment in Venture Round - Intercept Pharmaceuticals

balyasny-asset-management_image

Balyasny Asset Management

Balyasny Asset Management investment in Venture Round - Intercept Pharmaceuticals

rodman-renshaw_image

Rodman & Renshaw

Rodman & Renshaw investment in Debt Financing - Intercept Pharmaceuticals

Official Site Inspections

http://www.interceptpharma.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.45 K

  • Host name: server-3-167-112-127.iad55.r.cloudfront.net
  • IP address: 3.167.112.127
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Intercept Pharmaceuticals" on Search Engine

dfkcompany.com © 2022. All rights reserved